NecroIr1
NecroIr1 is an iridium (III) complex, serves as necroptosis inducers in Cisplatin -resistant lung cancer cells (A549R). NecroIr1 selectively accumulates in mitochondria, leading to oxidative stress and loss of mitochondrial membrane potential (MMP). NecroIr1 activates receptor-interacting serine-threonine kinase 3 (RIPK3) and Mixed Lineage Kinase (MLKL), and regulates CDK4 expression[1].
Product Specifications
UNSPSC
12352300
Target
CDK; Mixed Lineage Kinase; RIP kinase
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/necroir1.html
Concentration
10mM
Purity
98.02
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=CC(C2=[N]3C=CC(C4=NC(C=CC=C5)=C5O4)=C2)=[N]([Ir]67([N]8=CC=CC=C8C9=C7C=CC=C9)3[N]%10=CC=CC=C%10C%11=C6C=CC=C%11)C=C1.[Cl-]
Molecular Formula
C40H29ClIrN5O
Molecular Weight
823.36
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK4; RIPK1; RIPK3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CELA3B / ELA3B (Pancreatic Function Marker) (CELA3B/2809R), CF647 conjugate, 0.1mg/mL
